Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 13/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | TTR | P02766 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.64 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.64 |
| ▸ | PPARG | P37231 | 1/20 | 0.64 |
| ▸ | HTR2B | P41595 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.64 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.64 |
| ▸ | GALR3 | O60755 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GUCY1A1 | Q02108 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21753561 | 0.96 | PPARA (0.59) | PPARACYP2C9TSHRTTRCYP1A2 | |
| SCHEMBL21753558 | 0.93 | PPARA (0.55) | PPARACYP2C9TSHRTTRCYP1A2 | |
| SCHEMBL11090319 | 0.91 | PPARA (0.75) | PPARACYP2C9TSHRTTRCYP1A2 | |
| SCHEMBL21753593 | 0.89 | PPARA (0.50) | PPARACYP2C9TSHRTTRCYP1A2 | |
| SCHEMBL21753578 | 0.88 | PPARA (0.56) | PPARACYP2C9TSHRTTRCYP1A2 | |
| SCHEMBL21753557 | 0.88 | PPARA (0.56) | PPARACYP2C9TSHRTTRCYP1A2 | |
| SCHEMBL21753585 | 0.87 | PPARA (0.55) | PPARACYP2C9TSHRTTRCYP1A2 | |
| SCHEMBL9463720 | 0.86 | PPARA (0.64) | PPARACYP2C9TSHRTTRCYP1A2 | |
| SCHEMBL9701964 | 0.85 | PPARA (0.68) | PPARACYP2C9TSHRTTRCYP1A2 | |
| SCHEMBL9702591 | 0.85 | PPARA (0.68) | PPARACYP2C9TSHRTTRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313522-A1 | PHENOXY CARBOXYLIC ACID COMPOUNDS AND MEDICAL USES THEREOF | QINGDAO RISING BIOTECHNOLOGY CO., LTD (CN) | 2025-10-09 | — | — | US | claimed |
| US-12365643-B2 | Phenoxy carboxylic acid compounds and medical uses thereof | QINGDAO RISING BIOTECHNOLOGY CO., LTD (CN) | 2025-07-22 | — | — | US | claimed |
| CN-110857268-B | Phenoxy acid compound and medical application thereof | 青岛睿森生物科技有限公司 | 2022-10-04 | — | — | CN | claimed |
| US-20220119333-A1 | PHENOXY ACID COMPOUNDS AND MEDICAL USES THEREOF | QINGDAO WHOLESOMTECH CO., LTD. (CN) | 2022-04-21 | — | — | US | claimed |
| EP-3842410-A1 | FIBRIC ACID COMPOUND AND MEDICAL USE THEREOF | Beijing Wholesomeyird Sci & Tech Co., Ltd. (CN) | 2021-06-30 | — | — | EP | claimed |
| CN-110857268-A | Phenoxy acid compound and medical application thereof | 北京厚燊药德科技有限责任公司 | 2020-03-03 | — | — | CN | claimed |
| WO-2020038464-A1 | FIBRIC ACID COMPOUND AND MEDICAL USE THEREOF | 北京厚燊药德科技有限责任公司 | 2020-02-27 | — | — | WO | claimed |
| US-20250313522-A1 | PHENOXY CARBOXYLIC ACID COMPOUNDS AND MEDICAL USES THEREOF | QINGDAO RISING BIOTECHNOLOGY CO., LTD (CN) | 2025-10-09 | — | — | US | disclosed |
| US-12365643-B2 | Phenoxy carboxylic acid compounds and medical uses thereof | QINGDAO RISING BIOTECHNOLOGY CO., LTD (CN) | 2025-07-22 | — | — | US | disclosed |
| CN-114805054-B | Synthesis method of gemfibrozil Ji Xiu derivative | 浙江精进药业有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-117466745-A | Method for synthesizing arylamine compound by using photochemical manganese as catalyst | 陕西师范大学 | 2024-01-30 | — | — | CN | disclosed |
| CN-114773136-B | Method for synthesizing aromatic amine | 陕西师范大学 | 2023-06-16 | — | — | CN | disclosed |
| CN-110857268-B | Phenoxy acid compound and medical application thereof | 青岛睿森生物科技有限公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-114773136-A | Method for synthesizing arylamine | 陕西师范大学 | 2022-07-22 | — | — | CN | disclosed |
| US-20220119333-A1 | PHENOXY ACID COMPOUNDS AND MEDICAL USES THEREOF | QINGDAO WHOLESOMTECH CO., LTD. (CN) | 2022-04-21 | — | — | US | disclosed |
| US-20220119333-A1 | PHENOXY ACID COMPOUNDS AND MEDICAL USES THEREOF | QINGDAO WHOLESOMTECH CO., LTD. (CN) | 2022-04-21 | — | — | US | disclosed |
| EP-3842410-A1 | FIBRIC ACID COMPOUND AND MEDICAL USE THEREOF | Beijing Wholesomeyird Sci & Tech Co., Ltd. (CN) | 2021-06-30 | — | — | EP | disclosed |
| EP-3842410-A1 | FIBRIC ACID COMPOUND AND MEDICAL USE THEREOF | Beijing Wholesomeyird Sci & Tech Co., Ltd. (CN) | 2021-06-30 | — | — | EP | disclosed |
| CN-110857268-A | Phenoxy acid compound and medical application thereof | 北京厚燊药德科技有限责任公司 | 2020-03-03 | — | — | CN | disclosed |
| WO-2020038464-A1 | FIBRIC ACID COMPOUND AND MEDICAL USE THEREOF | 北京厚燊药德科技有限责任公司 | 2020-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119333-A1 | PHENOXY ACID COMPOUNDS AND MEDICAL USES THEREOF | PYGL, SLC10A1, GYS2 | PPARA 10/4885CYP2C9 56/4885TSHR 2406/4885 |
| US-12365643-B2 | Phenoxy carboxylic acid compounds and medical uses thereof | PYGL, SLC10A1, GYS2 | PPARA 9/4885CYP2C9 57/4885TSHR 2525/4885 |
| US-20250313522-A1 | PHENOXY CARBOXYLIC ACID COMPOUNDS AND MEDICAL USES THEREOF | PYGL, SLC10A1, GYS2 | PPARA 9/4885CYP2C9 57/4885TSHR 2525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.